Most Read Articles
02 Jul 2018
The use of beta-blockers in patients with heart failure with preserved ejection fraction (HFpEF), especially in those without histories of myocardial infarction, appears to increase the risk of adverse cardiovascular events, according to a recent study.
Stephen Padilla, 09 Jul 2018
Compared with warfarin, apixaban appears to be the safest drug among direct oral anticoagulants (DOACs), with decreased risks of major, intracranial and gastrointestinal bleeding, suggests a study. However, low-dose apixaban and rivaroxaban are associated with increased risks of all-cause mortality compared with warfarin.
24 Jun 2018
Sleep problems and depressive symptoms, and a combination of both, are differentially associated with the future incidence of physical illness, according to a study.
05 Jul 2018
Different measures of fitness and physical activity appear to be inversely associated with the risk of developing cardiovascular disease in the general population, as well as in individuals with elevated genetic risk for these diseases, according to a study.

Coffee consumption lowers risk of CVD, IHD mortality in MI patients

22 Oct 2017

Drinking coffee, whether caffeinated or decaffeinated, is associated with a reduced risk of cardiovascular disease (CVD) and ischaemic heart disease (IHD) mortality in patients with a prior myocardial infarction (MI), according to a recent study.

In this prospective study, researchers included 4,365 Dutch patients from the Alpha Omega Cohort (aged 60 to 80 years; 21 percent female) who suffered from an MI <10 years before study enrollment. They collected dietary data at baseline (2002 to 2006), including coffee consumption over the past month, with a 203-item validated food-frequency questionnaire.

Causes of death were monitored until 1 January 2013. Multivariable Cox proportional hazard models were used, adjusting for lifestyle and dietary factors, to estimate hazard ratios (HRs) for mortality in categories of coffee consumption.

Of the patients, 96 percent drank coffee, with a median of 375 mL/d (about 3 cups a day) total intake. A total of 945 patients died, including 396 CVD-related and 266 IHD-related deaths, during a median 7.1 years of follow-up.

An inverse association was observed between coffee consumption and CVD mortality, with HRs of 0.69 (95 percent CI, 0.54 to 0.89) for >2 to 4 cups/d and 0.72 (0.55 to 0.95) for >4 cups/d, compared with 0 to 2 cups/d. Corresponding HRs were 0.77 (0.57 to 1.05) and 0.68 (0.48 to 0.95) for IHD-related mortality and 0.84 (0.71 to 1.00) and 0.82 (0.68 to 0.98) for all-cause mortality, respectively.

There were similar associations for decaffeinated coffee and for coffee with additives.

“Consumption of coffee, one of the most popular beverages around the world, has been associated with a lower risk of cardiovascular and all-cause mortality in population-based studies,” according to researchers. 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
02 Jul 2018
The use of beta-blockers in patients with heart failure with preserved ejection fraction (HFpEF), especially in those without histories of myocardial infarction, appears to increase the risk of adverse cardiovascular events, according to a recent study.
Stephen Padilla, 09 Jul 2018
Compared with warfarin, apixaban appears to be the safest drug among direct oral anticoagulants (DOACs), with decreased risks of major, intracranial and gastrointestinal bleeding, suggests a study. However, low-dose apixaban and rivaroxaban are associated with increased risks of all-cause mortality compared with warfarin.
24 Jun 2018
Sleep problems and depressive symptoms, and a combination of both, are differentially associated with the future incidence of physical illness, according to a study.
05 Jul 2018
Different measures of fitness and physical activity appear to be inversely associated with the risk of developing cardiovascular disease in the general population, as well as in individuals with elevated genetic risk for these diseases, according to a study.